| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Chitinase-3-like protein 1|39 kDa synovial protein|Cartilage glycoprotein 39|CGP-39, GP-39, hCGP-39|YKL-40|CHI3L1 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human CHI3L1 (Chitinase-3-like protein 1) (39) is a molecular target commonly studied in immunology and signal transduction research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of CHI3L1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of CHI3L1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
CHI3L1 (Chitinase-3-like protein 1) (39) may also be referenced as Chitinase-3-like protein 1, 39 kDa synovial protein, and Cartilage glycoprotein 39 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how CHI3L1 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology and signal transduction research.
- Interpreting shifts in CHI3L1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
CHI3L1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology and signal transduction studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Single-cell profile reveals the landscape of cardiac immunity and identifies a cardio-protective Ym-1hi neutrophil in myocardial ischemia-reperfusion injury
IF: 18.9 Journal: Science Bulletin Author: Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China Cited Date: 2024-02-18
Effect of chitinase‐3‐like protein 1 on glucose metabolism: In vitro skeletal muscle and human genetic association study
IF: 5.391 Journal: FASEB Journal Cited Date: 2020-08-20
Interplay between Humoral and CLA+ T Cell Response against Candida albicans in Psoriasis
IF: 4.556 Journal: International Journal of Molecular Sciences Cited Date: 2021-02-19
The relationship between different stages of diabetic retinopathy and levels of YKL-40 in aqueous humour and serum
IF: 1.7 Journal: Clinical and Experimental Optometry Author: Department of Ophthalmology, Mustafa Kemal University, Hatay, Turkey. Cited Date: 2025-02-14
Serum YKL-40 (chitinase 3-like protein 1) levels in migraine patients during an attack
IF: Journal: Neurology Asia Author: Department of Neurology, Faculty of Medicine, KTO Karatay University, Konya, Turkey Cited Date: 2024-01-05